Journal article
Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome
Journal of molecular and cellular cardiology, Vol.85, pp.104-116
08/2015
DOI: 10.1016/j.yjmcc.2015.05.012
PMCID: PMC4530070
PMID: 26004364
Abstract
Cardiac dysfunction in obesity is associated with mitochondrial dysfunction, oxidative stress and altered insulin sensitivity. Whether oxidative stress directly contributes to myocardial insulin resistance remains to be determined. This study tested the hypothesis that ROS scavenging will improve mitochondrial function and insulin sensitivity in the hearts of rodent models with varying degrees of insulin resistance and hyperglycemia. The catalytic antioxidant MnTBAP was administered to the uncoupling protein-diphtheria toxin A (UCP-DTA) mouse model of insulin resistance (IR) and obesity, at early and late time points in the evolution of IR, and to db/db mice with severe obesity and type-two diabetes. Mitochondrial function was measured in saponin-permeabilized cardiac fibers. Aconitase activity and hydrogen peroxide emission were measured in isolated mitochondria. Insulin-stimulated glucose oxidation, glycolysis and fatty acid oxidation rates were measured in isolated working hearts, and 2-deoxyglucose uptake was measured in isolated cardiomyocytes. Four weeks of MnTBAP attenuated glucose intolerance in 13-week-old UCP-DTA mice but was without effect in 24-week-old UCP-DTA mice and in db/db mice. Despite the absence of improvement in the systemic metabolic milieu, MnTBAP reversed cardiac mitochondrial oxidative stress and improved mitochondrial bioenergetics by increasing ATP generation and reducing mitochondrial uncoupling in all models. MnTBAP also improved myocardial insulin mediated glucose metabolism in 13 and 24-week-old UCP-DTA mice. Pharmacological ROS scavenging improves myocardial energy metabolism and insulin responsiveness in obesity and type 2 diabetes via direct effects that might be independent of changes in systemic metabolism.
Details
- Title: Subtitle
- Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome
- Creators
- Olesya Ilkun - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USANicole Wilde - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USAJoseph Tuinei - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USAKarla M P Pires - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USAYi Zhu - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USAHeiko Bugger - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USAJamie Soto - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Fraternal Order of Eagles Diabetes Research Center, Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USABenjamin Wayment - Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT84112, USACurtis Olsen - Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT84112, USASheldon E Litwin - Division of Cardiology, University of Utah School of Medicine, Salt Lake City, UT84112, USAE Dale Abel - Division of Endocrinology, Metabolism, and Diabetes, Program in Molecular Medicine, University of Utah School of Medicine, Salt Lake City, UT 84112, USA; Fraternal Order of Eagles Diabetes Research Center, Division of Endocrinology and Metabolism, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA. Electronic address: DRCAdmin@uiowa.edu
- Resource Type
- Journal article
- Publication Details
- Journal of molecular and cellular cardiology, Vol.85, pp.104-116
- DOI
- 10.1016/j.yjmcc.2015.05.012
- PMID
- 26004364
- PMCID
- PMC4530070
- NLM abbreviation
- J Mol Cell Cardiol
- ISSN
- 0022-2828
- eISSN
- 1095-8584
- Publisher
- England
- Grant note
- T32 DK091317 / NIDDK NIH HHS U01 HL070525 / NHLBI NIH HHS UO1HL70525 / NHLBI NIH HHS R01HL73167 / NHLBI NIH HHS U54 HL112311 / NHLBI NIH HHS T32DK091317 / NIDDK NIH HHS R01 HL073167 / NHLBI NIH HHS
- Language
- English
- Date published
- 08/2015
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Fraternal Order of Eagles Diabetes Research Center; Biochemistry and Molecular Biology; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984025275102771
Metrics
43 Record Views